Schedule 13G ownership disclosure

Lexeo Therapeutics Inc

Common Stock, par value $0.0001 per share · CUSIP: 52886X107

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Vestal Point Capital, LP

    Shares: 3,228,161.00 · Class: 6.0%

  • Ryan Wilder

    Shares: 3,228,161.00 · Class: 6.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-003607
Form type
SCHEDULE 13G
Filer
Lexeo Therapeutics, Inc.
CIK
CIK 1907108
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub